Marc Beer is a co-founder and Chief Executive Officer of the Renovia Inc, a medical start-up based in Boston. In today’s advanced biotech industry, it requires significant skills and efforts to operate a start-up firm especially when it comes to matters such as research and development, and financing. Also, it may not be easy to get FDA approval for therapies and new drugs.
Marc Beer has been working extremely hard to build Renovia Inc. He has actually been able to raise about 42.3 U.S dollars to facilitate research in matters regarding pelvic disorders like urinary incontinence, a condition common in Women. According to statistics, over 250 million ladies from different corners of the world suffer from conditions associated with pelvic disorders.
Renovia’s efforts of getting therapies for making pelvic floor stronger are bearing fruits. The firm’s first item, Leva, was approved by the FDA in the month of April 2018. This product is actually an application for checking and promoting strength training as a way of curing pelvic floor disorders. This product comes with a special device that produces real-time visualization as well as coaching sessions. It helps to separate damaged levator plate muscles as well as directing optimal movement patterns.
Money acquired will be used to finance better iteration of Leva, additional wearable devices, clinical trials, and state-of-art office diagnostic equipment. Pelvic disorders can cause pain, pressure, improper bladder emptying that result in frequent urination as well as urinary incontinence. Women suffering from pelvic disorders can experience severe pain during sexual intercourse.
Marc Beer revealed that combining their innovative as well as proprietary sensor technologies with the right digital health platform can provide their customers with valuable information regarding the available treatment options. The move will also help reduce the general healthcare costs.
The fundraising for the Renovia Company included 10 million U.S. dollars of venture debt as well as 32.3 million U.S. dollars in series B equity. The funds will be used in areas like conducting trials, developing training and diagnostic devices, and shepherding items through FDA approval as well as commercialization. The activity was managed by the famous Perceptive Advisors & Ascension Ventures and involved stakeholders from the Western Technology Investment, OSF Ventures, and Longwood Fund.
Renovia’s products include proprietary algorithms, devices, sensors, and applications that work hard-in-hard to come up with dynamic as well as a static depiction of the pelvic floor, which is one of the main sources of the problems affecting women. Several ladies out there are usually shy and fear to talk about challenges associated with incontinence as well as frequent urination. Learn more: https://www.slideshare.net/MarcBeer
More about Marc Beer
Marc Beer has over 25 years of experience of development as well as commercialization in the field of pharmaceuticals, diagnostics, devices, and biotechnology. In the year 2016, Marc Beer, Yolanda Lorie, and Ramon Iglesias founded the Renovia Inc.